Skip to main content
. 2011 Dec 13;25(8):1447–1452. doi: 10.3109/14767058.2011.640368

Table III.

Comparison of serum concentrations of sFlt1, PlGF, and sEng among normotensive women who delivered preterm infants with or without respiratory distress syndrome, in specimens collected at 10–20 or 21–32 weeks.

RDS No RDS p value
Collected at 10–20 weeks
 Number of women 25 111
 GA at collection (weeks) 17.0 ± 0.5* 16.2 ± 0.2 NS±
 GA at delivery (weeks) 29.4 ± 0.8 34.7 ± 0.3 <0.001±
 Cesarean section 6 (24.0%) 10 (9.0%) NS±/NS
 Birth weight (g) 1404 ± 137 2315 ± 55 <0.001±/NS
 SGA 0 (0.0%) 8 (7.2%) NS±/NS
 sFlt1 (pg/mL) 3895 ± 494 3542 ± 177 NS±/NS
 PlGF (pg/mL) 207 ± 32 146 ± 12 0.05±/NS
 sEng (ng/mL) 6.30 ± 1.0 5.45 ± 0.1 NS±/NS
Collected at 21–32 weeks
 Number of women 14 117
 GA at collection (weeks) 26.5 ± 0.5 27.1 ± 0.1 NS±
 GA at delivery (weeks) 32.1 ± 0.9 35.2 ± 0.2 0.005±
 Cesarean section 3 (21.4%) 11 (9.4%) NS±/NS
 Birth weight (g) 1865 ± 169 2410 ± 42 <0.001±/NS
 SGA 0 (0.0%) 8 (6.8%) NS±/NS
 sFlt1 (pg/mL) 3645 ± 504 4430 ± 222 NS±/NS
 PlGF (pg/mL) 491 ± 63 706 ± 59 NS±/NS
 sEng (ng/mL) 5.32 ± 0.3 5.67 ± 0.2 NS±/NS
*

Data are presented as mean ± SD or N (%). RDS, respiratory distress syndrome; GA, gestational age; SGA, small for gestational age; sFlt1, soluble fms-like tyrosine kinase 1; PlGF, placental growth factor; sEng, soluble endoglin.

±

Indicates significance without adjustment.

Indicates significance with adjustment for gestational age at delivery.